Breast cancer is one of the most prevalent cancers among women worldwide, and researchers have long sought to understand the myriad factors that may influence its development. Among these factors, ...

DEAR DR. ROACH: I am a 63-year-old man. At a recent visit to my endocrinologist for my annual thyroid check (I have Hashimoto’s disease), I revealed that I have been suffering from fatigue and ...

Researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed antipsychotic medications are associated with a significant increase in risk of breast ...

A recent study found a minor link between prolactin levels and the risk of developing estrogen receptor (ER)-positive or ER-negative breast cancers. However, there was no association found between the ...

The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey ...

Dear Dr. Roach: I am a 63-year-old man. At a recent visit to my endocrinologist for my annual thyroid check (I have Hashimoto’s disease), I revealed that I have been suffering from fatigue and ...

New research provides more evidence that antipsychotics that raise prolactin levels are tied to a significantly increased risk for breast cancer. While the "absolute" breast cancer risk for these ...

I am a 63-year-old man. At a recent visit to my endocrinologist for my annual thyroid check (I have Hashimoto’s disease), I revealed that I have been suffering from fatigue and erectile dysfunction.

Nat Clin Pract Endocrinol Metab. 2006;2(6):298-299. Clearly, dopamine agonists should not be withdrawn too early, and certainly not before completion of 12 months' treatment. Until more is known about ...